Stryker (SYK) Research & Development (2009 - 2026)

Stryker (SYK) has reported Research & Development for 18 consecutive years, with $434.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 6.63% year-over-year to $434.0 million in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 7.18% increase from a year earlier, with the FY2025 full-year figure at $1.6 billion, up 10.71% from the prior year.
• Research & Development was $434.0 million for Q2 2026 at Stryker, up from $413.0 million in the prior quarter.
• Over five years, Research & Development peaked at $434.0 million in Q2 2026 and troughed at $326.0 million in Q4 2022.
• A 5-year average of $376.6 million and a median of $366.0 million in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development jumped 43.4% in 2022 and fell 17.92% in 2023, its largest moves.
• Over 5 years, Research & Development stood at $326.0 million in 2022, then increased by 7.36% to $350.0 million in 2023, then grew by 2.29% to $358.0 million in 2024, then rose by 12.01% to $401.0 million in 2025, then grew by 8.23% to $434.0 million in 2026.
• The last three Research & Development figures came in at $434.0 million (Q2 2026), $413.0 million (Q1 2026), and $401.0 million (Q4 2025), per Business Quant data.